Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amsurg Corp Raises Low End Of Prior FY 2012 Guidance To A Range In Line With Analysts' Estimates; Issues Q4 2012 EPS Guidance Below Analysts' Estimates


Tuesday, 23 Oct 2012 04:15pm EDT 

Amsurg Corp announced that for fiscal 2012, it expects revenues in a range of $915 million to $925 million compared with the previous range of $905 million to $925 million. Net earnings from continuing operations per diluted share attributable to common shareholders in a range of $1.98 to $2.01 compared with the previous range of $1.97 to $2.01. For the fourth quarter of 2012, it expects earnings per share (EPS) to be in a range of $0.48-$0.51. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $2.01 on revenue of $925 million for fiscal 2012; EPS of $0.52 for the fourth quarter of 2012. 

Company Quote

47.76
-1.0 -2.05%
31 Jul 2014